Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 187
1
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several decades...

Regulation of Spore Dormancy in Pathogenic Fungi

Tiny fungal spores and yeast forms are found in the soil, air, and water. Infection takes hold when spores break...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

Backer Badge Funded